SCHEMBL7212876

SCHEMBL7212876

CC(C)(C)c1cccc(CC(CCCS)(C(=O)O)C(=O)O)c1

nearest known ligand 0.42

Predicted protein targets (top 18)

geneUniProtsupporting neighboursconfidence
CYP1A2 P05177 1/20 0.42
CYP2C19 P33261 1/20 0.42
BCHE P06276 3/20 0.39
ACHE P22303 3/20 0.38
CYP26A1 O43174 1/20 0.38
CYP26B1 Q9NR63 1/20 0.38
RXRA P19793 1/20 0.38
RXRB P28702 1/20 0.38
AMPD3 Q01432 1/20 0.38
CCR9 P51686 1/20 0.37
BACE1 P56817 2/20 0.36
NR1H4 Q96RI1 2/20 0.36
FOLH1 Q04609 3/20 0.36
NOTUM Q6P988 1/20 0.36
MRGPRX4 Q96LA9 1/20 0.36
HDAC4 P56524 1/20 0.36
HDAC2 Q92769 1/20 0.36
HDAC8 Q9BY41 1/20 0.36

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL5053174 0.81 SMN1; SMN2 (0.47) CYP1A2CYP2C19AMPD3FOLH1HDAC4
SCHEMBL9063423 0.77 CYP1A2 (0.36) CYP1A2CYP2C19BCHEACHECYP26A1
SCHEMBL9810139 0.76 RXRA (0.39) CYP1A2RXRARXRBHDAC2HDAC8
SCHEMBL31414274 0.74 CYP1A2 (0.48) CYP1A2CYP2C19BCHEACHERXRA
SCHEMBL5060115 0.73 FOLH1 (0.67) FOLH1
SCHEMBL5051190 0.73 SMN1; SMN2 (0.46) CYP1A2AMPD3FOLH1HDAC4HDAC2
SCHEMBL28003878 0.71 SMN1; SMN2 (0.47)
SCHEMBL14508866 0.70 TP53 (0.37) RXRARXRBNR1H4FOLH1MRGPRX4
SCHEMBL31147036 0.70 SMN1; SMN2 (0.46) AMPD3
SCHEMBL892932 0.70 CYP1A2 (0.71) CYP1A2CYP2C19ACHECYP26A1CYP26B1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1353903-A2 THIOL-BASED NAALADASE INHIBITORS GUILFORD PHARMACEUTICALS INC. (US) 2003-10-22 EP disclosed
WO-2002057222-A2 THIOL-BASED NAALADASE INHIBITORS GUILFORD PHARMACEUTICALS INC. (US) 2002-07-25 WO disclosed